文献速递血液净化与透析

血液透析患者丙型肝炎病毒的患病率、发病率及危险因素

Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients.
PubMed 文献 · Kidney Int · 2019-01-01

基于DOPPS 1996-2015数据,2012-2015年透析患者HCV患病率近10%,各国差异大(比利时4%至中东20%),多数国家患病率下降,发病率从2.9降至1.2/100患者年。透析中心高HCV患病率是血清阳转的强设施级危险因素,隔离站使用与血清阳转率无显著降低相关。

要点

  • 血透患者HCV患病率仍近10%,高于一般人群。
  • 多数国家HCV患病率随时间下降,发病率从2.9降至1.2/100患者年。
  • 透析中心高HCV患病率是血清阳转的强危险因素,隔离站未显著降低阳转率。

核心结论

  • 尽管血透患者HCV患病率呈下降趋势,但仍高于一般人群。
  • 透析中心高HCV患病率是血清阳转的强设施级危险因素,隔离站使用未显著降低血清阳转率。

研究设计与样本

  • 基于DOPPS(1996-2015)的多国前瞻性观察研究,对象为 prevalent 血液透析患者。
  • HCV感染定义为有记录的诊断或抗体阳性。

主要发现

  • 2012-2015年 prevalent 血透患者HCV患病率近10%。
  • 患病率范围从比利时4%至中东高达20%,中国、日本、意大利、西班牙和俄罗斯为中间水平。
  • 多数参与多阶段DOPPS的国家HCV患病率随时间下降;近期(<4个月)开始透析的患者患病率约5%。
  • 参与初始DOPPS阶段的国家HCV发病率从2.9降至1.2/100患者年。
  • 多数透析单位无血清阳转,但10%的单位在中位1.1年内发生3例或以上。

临床怎么用

  • 应关注透析中心层面的HCV患病率,高患病率单位需加强感染控制。
  • 隔离站使用未显示显著降低HCV血清阳转率,需综合防控策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatitis C virus (HCV) infection is common in dialysis patients and is associated with increased morbidity and mortality. We used the Dialysis Outcomes and Practice Patterns Study (DOPPS, 1996-2015) to assess trends in the prevalence, incidence, and risk factors for HCV infection as defined by a documented diagnosis or antibody positivity. Among prevalent hemodialysis patients, HCV prevalence was nearly 10% in 2012-2015. Prevalence ranged from 4% in Belgium to as high as 20% in the Middle East, with intermediate prevalence in China, Japan, Italy, Spain, and Russia. HCV prevalence decreased over time in most countries participating in more than one phase of DOPPS, and prevalence was around 5% among patients who had recently (<4 months) initiated dialysis. The incidence of HCV infection decreased from 2.9 to 1.2 per 100 patient-years in countries participating in the initial phase of DOPPS. Although most units reported no seroconversions, 10% of units experienced 3 or more cases over a median of 1.1 years. High HCV prevalence in the hemodialysis unit was a powerful facility-level risk factor for seroconversion, but the use of isolation stations for HCV-positive patients was not associated with significantly lower seroconversion rates. Overall, despite a trend toward lower HCV prevalence among hemodialysis patients, the prevalence of HCV infection remains higher than in the general population. Combined with a high prevalence of HCV infection among patients with Stage 5 CKD, high rates of HCV seroconversion in a subset of hemodialysis units may contribute to this disparity.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Jadoul M, Bieber BA, Martin P, et al. Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients. Kidney Int. 2019. PMID: 30904068. doi:10.1016/j.kint.2018.11.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。